Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juan Francisco Galan-Herrera"'
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
Autor:
Shibadas Biswal, Jorge Fernando Mendez Galvan, Mercedes Macias Parra, Juan-Francisco Galan-Herrera, Monica Belisa Carrascal Rodriguez, Esteban Patricio Rodriguez Bueno, Manja Brose, Martina Rauscher, Inge LeFevre, Derek Wallace, Astrid Borkowski
Publikováno v:
Revista Panamericana de Salud Pública, Vol 45, Iss 67, Pp 1-11 (2021)
Objective. To describe the immunogenicity and safety of a tetravalent dengue vaccine (TAK-003) in healthy adolescents living in Mexico City, an area considered non-endemic for dengue (NCT03341637). Methods. Participants aged 12–17 years were random
Externí odkaz:
https://doaj.org/article/3e634197f1df46e6bd0517825679a613
Autor:
Salvador Namur, Victoria Burke-Fraga, Juan Francisco Galan-Herrera, Elvira Fuentes-Fuentes, Mario González-de la Parra, Oscar Rosales-Sanchez, Lizbeth Cariño, Jorge Luis Poo
Publikováno v:
Clinical Therapeutics. 31:1796-1803
Background: Levofloxacin is a synthetic fluoroquinolone with a broad spectrum of antibacterial activity. It is indicated for the treatment of respiratory, sinus, skin, and urinary tract infections. Although generic formulations of oral levofloxacin a
Autor:
Salvador Namur, Ericka López-Bojórquez, Iván Oliva, Patricia Jiménez, Jorge Luis Poo, Victoria Burke-Fraga, Jose Alfonso Maya-Barrios, Alberto de Lago, Juan Francisco Galan-Herrera, Mario González-de la Parra
Publikováno v:
Clinical therapeutics. 30(9)
Ketorolac tromethamine (ie, ketorolac) is an NSAID that appears to have several mechanisms of action, including inhibition of prostaglandin synthesis, modulatory effect on opioid receptors, and nitric oxide synthesis. Ketorolac is used in the treatme